“Although the regulator allows sponsored depository receipts, the process involves cost as well as local and foreign regulatory approval,” said Gidwani. In October last year, the Securities and Exchange Board of India (Sebi) put in place a framework for domestic companies to raise capital through DRs. The move, which followed a Budget announcement last year, will allow listed Indian companies to issue either equity or debt to investors on overseas stock exchanges such as the New York Stock Exchange, Nasdaq, and the Hong Kong Stock Exchange.
The new guidelines have failed to spur Indian companies’ interest in this segment. The DR market has also been suffering from a trust deficit because of either lack of quality disclosures, or market manipulation, or fraudulent arrangements, and in some cases it is even being used as a tool for money laundering, said Yogesh Chande, partner, Shardul Amarchand Mangaldas.